Skip to Content

Λ13 (Oxybutynin Chloride Extended-Release 5 mg)

Pill with imprint Λ13 is Pink, Round and has been identified as Oxybutynin Chloride Extended-Release 5 mg. It is supplied by Advagen Pharma Limited.

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Λ13

Oxybutynin Chloride Extended-Release

Imprint
Λ13
Strength
5 mg
Color
Pink
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Advagen Pharma Limited
Manufacturer
Rubicon Research Private Limited
National Drug Code (NDC)
72888-0030

Get help with Imprint Code FAQs.

Related Images for "Λ13"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.